Abstract
Canada and France do not have a lot of sunshine but skin cancer is still the most common tumor. The majority of the population is white. The pattern of care for skin cancers is similar to the delivery of care for other cancers. No extra resources are allocated to skin cancer. The general practitioners are the first care providers for skin cancers. Excision or biopsy of the skin lesion establishes the diagnosis. If residual disease is present, further treatments are provided by general practitioners, dermatologists, general or plastic surgeons and radiation oncologists. If adjuvant or definitive treatments are required, patients are referred to cancer services to consider radiotherapy, chemotherapy, targeted therapy or immunotherapy. Both Canada and France have waiting lists for referrals.
Keywords: Pattern of care, rare tumors, registry, skin tumor, treatment.
Current Cancer Therapy Reviews
Title:Pattern of Care for Skin Cancers - Canada and France
Volume: 12 Issue: 2
Author(s): Khanh Vu, Patricia Tai, Avi Assouline and Claude Krzisch
Affiliation:
Keywords: Pattern of care, rare tumors, registry, skin tumor, treatment.
Abstract: Canada and France do not have a lot of sunshine but skin cancer is still the most common tumor. The majority of the population is white. The pattern of care for skin cancers is similar to the delivery of care for other cancers. No extra resources are allocated to skin cancer. The general practitioners are the first care providers for skin cancers. Excision or biopsy of the skin lesion establishes the diagnosis. If residual disease is present, further treatments are provided by general practitioners, dermatologists, general or plastic surgeons and radiation oncologists. If adjuvant or definitive treatments are required, patients are referred to cancer services to consider radiotherapy, chemotherapy, targeted therapy or immunotherapy. Both Canada and France have waiting lists for referrals.
Export Options
About this article
Cite this article as:
Vu Khanh, Tai Patricia, Assouline Avi and Krzisch Claude, Pattern of Care for Skin Cancers - Canada and France, Current Cancer Therapy Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573394712666160725155135
DOI https://dx.doi.org/10.2174/1573394712666160725155135 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Products as Anti-Invasive and Anti-Metastatic Agents
Current Medicinal Chemistry Review of the Contribution of Radiolabelled Tracers for Tumour Cell Status Imaging
Current Medical Imaging Brief Academic Review and Clinical Practice Guidelines for Pediatric Atopic Dermatitis
Current Pediatric Reviews Lipid-Induced Modulation of Protective Signalling Pathways in Cardiovascular Disease: The Role of High Density Lipoproteins
Current Signal Transduction Therapy A QSAR Study on a Series of Indolin-2-Ones Acting as Non-Receptor Src Tyrosine Kinase Inhibitors
Letters in Drug Design & Discovery Determination of 7,12-Dimethylbenz[a]Anthracene in Orally Treated Rats by High-Performance Liquid Chromatography and Transfer Stripping Voltammetry
Combinatorial Chemistry & High Throughput Screening Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Topical Chemoprevention of Skin Cancers with Phytochemicals
Current Cancer Therapy Reviews Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Current Gene Therapy Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery A Single Fas Gene Mutation Changes Lupus Onset, Severity, Location, and Molecular Abnormalities in Mice
Current Molecular Medicine Meet Our Editorial Board Member:
Reviews on Recent Clinical Trials Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
Current Drug Targets Revisiting Non-Cancer Drugs for Cancer Therapy
Current Topics in Medicinal Chemistry Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Inflammation & Allergy - Drug Targets (Discontinued) Criteria of Evidence to Move Potential Chemopreventive Agents into Late Phase Clinical Trials
Current Drug Targets Synthesis and Hypoxia Selective Radiosensitization Potential of β-2-FAZA and β-3-FAZL: Fluorinated Azomycin β-Nucleosides
Medicinal Chemistry Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Pharmaceutical Production of Anti-tumor and Immune-potentiating Enterococcus faecalis-2001 β-glucans: Enhanced Activity of Macrophage and Lymphocytes in Tumor-implanted Mice
Current Pharmaceutical Biotechnology In vitro effects of infrared A radiation on the synthesis of MMP-1, catalase, superoxide dismutase and GADD45 alpha protein
Inflammation & Allergy - Drug Targets (Discontinued)